Skip to main content
TipRanks
Go Ultimate75% OFF

Corteva (CTVA) AI Stock Analysis

1,878 Followers
CTVA

Corteva

(NYSE:CTVA)

Select Model
Rating:59Neutral
Price Target:$9.50▲(0.74% Upside)
Action:reiterated
Date:11/13/26

CTVA scores as a mid-range setup: financials show improving margins and low leverage, but the recent TTM cash flow reversal is the biggest fundamental risk. Technically, the stock is in a pronounced downtrend (below all major DMAs with negative MACD), though it is deeply oversold (low RSI). Valuation is a notable offset with a low P/E and a modest dividend, while the latest earnings call was tempered by reduced EBITDA guidance and Brazil/channel-inventory headwinds.

Positive Factors
New-product momentumStrong volume growth across regions indicates that Corteva’s innovation pipeline is translating into customer adoption. Continued uptake of new products can support market-share gains, improve product mix, and partly offset pricing pressure over the next several quarters.
Negative Factors
Weak recent cash conversionThe sharp deterioration in operating and free cash flow creates a meaningful quality-of-earnings concern. If cash conversion remains weak, Corteva may have less flexibility to fund R&D, dividends, capital spending, or strategic actions from internally generated resources.

Corteva Key Performance Indicators (KPIs)

Seed Sales by SegmentTracks revenue from seed sales across various segments, indicating market demand and competitive positioning in the agriculture sector.

$0.00$1.00B$2.00B$3.00B$4.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Corn is the clear growth engine—seasonal planting spikes are recurring, and Q1 2026 shows an outsized corn uplift that matches management’s reported seed volume and price/mix strength plus royalty improvement. That Q1 gain likely includes timing (early planting) so some pullback into later quarters is possible, but licensing momentum in Brazil and productivity tailwinds support the company’s guidance; monitor acreage mix shifts and energy/input cost risks that could temper sustained upside.

Data provided by:The Fly

Corteva (CTVA) vs. SPDR S&P 500 ETF (SPY)

-10%0%10%20%30%40%50%60%CTVA-1.64%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$6.29B
Dividend Yield
1.15%
Average Volume (3M)
18.83M
Price to Earnings (P/E)
7.8
Beta (1Y)
0.36
Revenue Growth
1.05%
EPS Growth
-51.65%
Country
US
Employees
21,500
Sector
Basic Materials
Sector Strength
61
Industry
Agricultural Inputs

Corteva Business Overview & Revenue Model

Company Description

Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait techno...

How the Company Makes Money

Corteva makes money primarily by selling agricultural inputs to farmers and distributors, with revenue concentrated in two main streams: (1) Seed and (2) Crop Protection. In Seed, Corteva generates sales from proprietary seed products (notably corn a...

Corteva Earnings Call Summary

Earnings Call Date:Nov 11, 2026(Q3-2026)|% Change Since:-22.32%|Next Earnings Date:Feb 03, 2027
Earnings Call SentimentNegative

The call presented strong execution, innovation, productivity and growth across North America, EMEA and Asia Pacific, supported by new product growth and expanded year-to-date margins. However, the significant deterioration in Brazil, elevated channel inventory, pricing pressure, lower full-year EBITDA guidance and an expected fourth-quarter EBITDA decline were central to the discussion. The negative Brazil-driven outlook outweighed the otherwise solid performance in the rest of the business.

Positive Updates

New Product Volumes Increased Across All Regions
New product volumes grew 20% in the quarter, with growth in every region, while pricing for this group of products was relatively stable. Year-to-date new product sales volume was up 14%.

Negative Updates

Third-Quarter Sales and EBITDA Declined
Third-quarter net sales were $1.6 billion, down 9% versus the prior year on both a reported and organic basis. Operating EBITDA was $222 million, down 17%, and operating EBITDA margin was 14%, down 140 basis points.

Company Guidance

Corteva updated 2026 stand-alone operating EBITDA guidance to a range of $1.1 billion to $1.125 billion, with full year operating EBITDA expected to be down 12% versus last year at the midpoint and operating EBITDA margin of about 15%; fourth quarter EBITDA is expected to be about half of 2025 levels on an adjusted pro forma basis, operating EPS is expected to be in the range of $0.76 to $0.80 per share, up about 3% at the midpoint, and the full year EBITDA impact related to elevated channel inventory is estimated at approximately $100 million. Fourth quarter revenue is expected to be around $2 billion, down year-over-year, with volumes generally flat year-over-year and pricing down high single digits; U.S. acetochlor is expected to contribute a fourth-quarter headwind closer to that $40-ish million level, with a little bit of it in the first quarter and no year-over-year headwinds expected by the second quarter of 2027. Corteva remains on track for a year-end cash position of about $1.5 billion, around $1 billion of financial debt, underlying fourth-quarter CapEx of about $50 million, and expects to grow the business in 2027.

Corteva Financial Statement Overview

Summary

Operating fundamentals are mixed: revenue has been broadly flat with improved gross margin and operating profitability, and the balance sheet is conservatively levered. The main drag is TTM cash conversion—very low operating cash flow and negative free cash flow despite positive earnings—raising near-term quality-of-earnings and flexibility concerns alongside a jump in total debt in TTM.

Income Statement

64Positive

Balance Sheet

78Positive

Cash Flow

42Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue17.65B17.40B16.91B17.23B17.45B15.65B
Gross Profit8.58B8.23B7.38B7.31B7.02B6.43B
EBITDA3.06B3.07B2.73B2.54B2.73B3.62B
Net Income759.00M1.09B907.00M735.00M1.15B1.76B
Balance Sheet
Total Assets43.03B42.84B40.83B43.00B42.62B42.34B
Cash, Cash Equivalents and Short-Term Investments3.93B4.53B3.17B2.74B3.31B4.54B
Total Debt7.45B2.58B2.70B2.49B1.31B1.12B
Total Liabilities18.29B18.46B16.80B17.72B17.08B16.72B
Stockholders Equity24.49B24.14B23.79B25.04B25.30B25.38B
Cash Flow
Free Cash Flow-149.00M2.81B1.55B1.17B267.00M2.15B
Operating Cash Flow427.00M3.41B2.15B1.77B872.00M2.73B
Investing Cash Flow-578.00M-543.00M-589.00M-1.99B-632.00M-362.00M
Financing Cash Flow1.79B-1.64B-1.20B-99.00M-1.18B-1.27B

Corteva Technical Analysis

Technical Analysis SentimentNegative
Last Price9.43

Price Trends

50DMA12.30Negative
100DMA12.38Negative
200DMA12.09Negative

Market Momentum

MACD-0.52Positive
RSI27.39Positive
STOCH23.16Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTVA, the sentiment is Negative. The current price of 9.43 is below the 20-day moving average (MA) of 11.83, below the 50-day MA of 12.30, and below the 200-day MA of 12.09, indicating a bearish trend. The MACD of -0.52 indicates Positive momentum. The RSI at 27.39 is Positive, neither overbought nor oversold. The STOCH value of 23.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CTVA.

Corteva Risk Analysis

Corteva disclosed 31 risk factors in its most recent earnings report. Corteva reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

Corteva Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

CTVA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
CFCF77Outperform$18.30B8.8040.30%1.76%17.87%70.91%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
CTVACTVA59Neutral$6.29B7.793.09%1.15%1.05%-51.65%
ICLICL55Neutral$5.83B18.645.09%4.56%10.15%-15.98%
MOSMOS47Neutral$6.97B-16.48-3.78%4.01%0.02%-191.20%
FMCFMC42Neutral$810.46M-0.16-308.88%6.14%-21.99%-677.23%
BIOXBIOX38Underperform$13.40M-0.06-216.09%―-26.10%14.85%

* Basic Materials Sector Average

Performance Comparison

-50%0%50%CTVACFFMCMOSICLBIOXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CTVA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CTVACorteva9.43-0.06-0.67%
CFCf Industries Holdings, Inc.125.0945.5657.30%
FMCFMC Corp5.21-7.40-58.69%
MOSMosaic Co21.92-1.73-7.32%
ICLIcl Group Ltd.4.52-0.70-13.39%
BIOXBioceres Crop Solutions0.21-1.33-86.41%

Corteva Corporate Events

Business Operations and StrategyStock BuybackDividendsLegal Proceedings

Corteva separation faces legal challenge and appellate review

Negative
Oct 13, 2026

On October 1, 2026, Corteva, Inc. completed its separation from Vylor Inc. into two independent, publicly traded companies, a transaction that was immediately challenged by litigation brought by 15 states and one sovereign in the U.S. District Court...

Business Operations and StrategyPrivate Placements and Financing

Corteva Subsidiary Streamlines Debt Through Note Exchange

Positive
Oct 7, 2026

On October 1, 2026, Vylor Inc. completed private exchange offers for multiple series of outstanding senior notes issued by Corteva’s subsidiary EIDP, Inc., swapping them for new Vylor notes held by eligible investors and conducting related consent so...

Business Operations and StrategyDelistings and Listing ChangesM&A Transactions

Corteva completes spin-off of seed business into Vylor

Positive
Oct 5, 2026

At 12:03 a.m. New York City time on October 1, 2026, Corteva completed the previously announced spin-off of its seed operating segment into Vylor Inc., which became an independent, publicly traded company listed on the New York Stock Exchange under t...

Business Operations and StrategyDelistings and Listing ChangesM&A Transactions

Corteva completes spin-off of seed business Vylor

Positive
Oct 1, 2026

On October 1, 2026, Corteva completed the previously announced separation of its seed operating segment into a standalone, publicly traded company, Vylor Inc., via a pro rata distribution of Vylor shares to Corteva shareholders of record as of Septem...

Business Operations and StrategyPrivate Placements and Financing

Corteva Realigns Debt Structure Ahead Planned Separation

Positive
Oct 1, 2026

On October 1, 2026, Corteva announced that its wholly owned subsidiary Vylor Inc. had completed private exchange offers and related consent solicitations for three series of EIDP, Inc. senior notes, which expired on September 30, 2026. Participation...

Business Operations and StrategyDividendsLegal ProceedingsM&A Transactions

Corteva completes Vylor seed business spin-off despite challenge

Positive
Oct 1, 2026

On September 30, 2026, the U.S. Court of Appeals for the Fourth Circuit reversed a District Court order that had blocked California from seeking to delay Corteva’s planned separation of its seed business into Vylor Inc., remanding the case without ru...

Business Operations and StrategyPrivate Placements and Financing

Corteva extends debt exchange ahead planned business separation

Positive
Sep 30, 2026

On September 30, 2026, Corteva’s subsidiary Vylor Inc. extended by one day, to 5:00 p.m. New York City time on September 30, 2026, the expiration date for its private exchange offers and related consent solicitations involving EIDP, Inc.’s 2.300% 203...

Business Operations and StrategyDelistings and Listing ChangesRegulatory Filings and Compliance

Corteva Announces Spin-Off and NYSE Listing of Vylor

Positive
Sep 25, 2026

On September 24, 2026, Corteva announced that the U.S. Securities and Exchange Commission had declared effective Vylor’s Form 10 registration statement, detailing the planned separation of Vylor into an independent, publicly traded company. The move...

Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance

Corteva’s EIDP Registers Notes, Advancing Separation Plan

Positive
Sep 24, 2026

In connection with its planned separation into two publicly traded companies announced on October 1, 2025, Corteva’s affiliate EIDP, Inc. privately issued $700 million of 6.000% senior notes due August 15, 2036, with semiannual interest payments begi...

Business Operations and StrategyRegulatory Filings and Compliance

Corteva Advances Vylor Seed Business Spin-Off Plans

Positive
Sep 21, 2026

On September 21, 2026, Corteva subsidiary Vylor, Inc. filed Amendment No. 3 to its Form 10 registration statement with the U.S. Securities and Exchange Commission, advancing Corteva’s previously announced plan to separate its seed operating segment i...

Business Operations and StrategyDelistings and Listing Changes

Corteva Advances Vylor Spin-Off and Investor Day Plans

Positive
Sep 15, 2026

On September 12, 2026, Corteva’s board of directors approved the previously announced plan to separate its seed operating segment into Vylor, Inc., creating two independent, publicly traded agriculture companies. The spin-off will be executed via a p...

Business Operations and StrategyLegal Proceedings

Corteva, DuPont, Chemours Settle North Carolina PFAS Claims

Positive
Sep 10, 2026

On September 9, 2026, Corteva, DuPont and Chemours reached a comprehensive settlement with the State of North Carolina and several local governments to resolve statewide PFAS claims and Fayetteville Works site related claims, including all historical...

Business Operations and StrategyPrivate Placements and Financing

Corteva Advances Seed Business Spin-Off Via Vylor Notes

Positive
Aug 31, 2026

On October 1, 2025, Corteva’s board approved a plan to separate the company into two listed businesses, one for crop protection and one for seeds, with the seed business to be owned and operated by Vylor Inc. In preparation for this separation, Vylor...

Business Operations and StrategyPrivate Placements and Financing

Corteva Advances Separation with Key Debt Indenture Changes

Neutral
Aug 20, 2026

In August 2026, Corteva advanced its planned separation into two publicly traded companies, one for crop protection and one for seeds, by having Vylor Inc. launch private exchange offers for several series of senior notes issued by subsidiary EIDP, I...

Business Operations and StrategyPrivate Placements and Financing

Corteva advances note exchange ahead planned business separation

Positive
Aug 20, 2026

On August 20, 2026, Corteva announced that its subsidiary Vylor Inc. had secured the required majority consents from holders of EIDP, Inc. senior notes due 2030, 2032 and 2033 for private exchange offers and related indenture amendments, with early t...

Business Operations and StrategyRegulatory Filings and Compliance

Corteva Advances Vylor Spin-Off With Amended Filing

Positive
Aug 14, 2026

On August 14, 2026, Vylor, Inc., a subsidiary of Corteva, filed the first amendment to its Form 10 registration statement with the U.S. Securities and Exchange Commission, detailing Vylor’s business, strategy and historical financial results. The fil...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 13, 2026